Global NGS-Based Monitoring and Diagnostic Test Market Growth (Status and Outlook) 2023-2029

March 2023 | 94 pages | ID: GB111FEF4C24EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.

According to this study, the global NGS-Based Monitoring and Diagnostic Test market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of NGS-Based Monitoring and Diagnostic Test market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Commercial Assays/Tests
• Laboratory Developed Tests
• Direct to Consumer Test
• Pre-Commercial Tests

Segmentation by Application:

• Out-Patient Clinics/General Practitioners
• Diagnostic Centers
• Hospitals
• Others

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Agilent Technologies, Inc.
• Ancestry.com LLC
• ArcherDX, Inc.
• Beijing Genomics Institute (BGI)
• Cancer Genetics, Inc.
• CENTOGENE AG
• F. Hoffmann-La Roche Ltd
• GenePath Dx
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Siemens Healthineers, Inc.
• Thermo Fisher Scientific Inc.
• HTG Molecular Diagnostics, Inc.
• Vela Diagnostics Pte. Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global NGS-Based Monitoring and Diagnostic Test Market Size 2024-2029
  2.1.2 NGS-Based Monitoring and Diagnostic Test Market Size CAGR by Region
2.2 NGS-Based Monitoring and Diagnostic Test Segment by Type
  2.2.1 Commercial Assays/Tests
  2.2.2 Laboratory Developed Tests
  2.2.3 Direct to Consumer Test
  2.2.4 Pre-Commercial Tests
2.3 NGS-Based Monitoring and Diagnostic Test Market Size by Type
  2.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
  2.3.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (2024-2029)
2.4 NGS-Based Monitoring and Diagnostic Test Segment by Application
  2.4.1 Out-Patient Clinics/General Practitioners
  2.4.2 Diagnostic Centers
  2.4.3 Hospitals
  2.4.4 Others
2.5 NGS-Based Monitoring and Diagnostic Test Market Size by Application
  2.5.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
  2.5.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Application (2024-2029)

3 NGS-BASED MONITORING AND DIAGNOSTIC TEST KEY PLAYERS

3.1 Date of Key Players Enter into NGS-Based Monitoring and Diagnostic Test
3.2 Key Players NGS-Based Monitoring and Diagnostic Test Product Offered
3.3 Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players NGS-Based Monitoring and Diagnostic Test Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 NGS-BASED MONITORING AND DIAGNOSTIC TEST BY REGIONS

4.1 NGS-Based Monitoring and Diagnostic Test Market Size by Regions (2024-2029)
4.2 United States NGS-Based Monitoring and Diagnostic Test Market Size Growth (2024-2029)
4.3 China NGS-Based Monitoring and Diagnostic Test Market Size Growth (2024-2029)
4.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size Growth (2024-2029)
4.5 Rest of World NGS-Based Monitoring and Diagnostic Test Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029)
5.2 United States NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029)
6.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029)

7 CHINA

7.1 China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029)
7.2 China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029)
8.2 Rest of World NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN NGS-BASED MONITORING AND DIAGNOSTIC TEST

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Agilent Technologies, Inc.
  11.1.1 Agilent Technologies, Inc. Company Details
  11.1.2 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
  11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.1.4 Agilent Technologies, Inc. Main Business Overview
  11.1.5 Agilent Technologies, Inc. News
11.2 Ancestry.com LLC
  11.2.1 Ancestry.com LLC Company Details
  11.2.2 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Offered
  11.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.2.4 Ancestry.com LLC Main Business Overview
  11.2.5 Ancestry.com LLC News
11.3 ArcherDX, Inc.
  11.3.1 ArcherDX, Inc. Company Details
  11.3.2 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
  11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.3.4 ArcherDX, Inc. Main Business Overview
  11.3.5 ArcherDX, Inc. News
11.4 Beijing Genomics Institute (BGI)
  11.4.1 Beijing Genomics Institute (BGI) Company Details
  11.4.2 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Offered
  11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.4.4 Beijing Genomics Institute (BGI) Main Business Overview
  11.4.5 Beijing Genomics Institute (BGI) News
11.5 Cancer Genetics, Inc.
  11.5.1 Cancer Genetics, Inc. Company Details
  11.5.2 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
  11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.5.4 Cancer Genetics, Inc. Main Business Overview
  11.5.5 Cancer Genetics, Inc. News
11.6 CENTOGENE AG
  11.6.1 CENTOGENE AG Company Details
  11.6.2 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Offered
  11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.6.4 CENTOGENE AG Main Business Overview
  11.6.5 CENTOGENE AG News
11.7 F. Hoffmann-La Roche Ltd
  11.7.1 F. Hoffmann-La Roche Ltd Company Details
  11.7.2 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Offered
  11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.7.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.7.5 F. Hoffmann-La Roche Ltd News
11.8 GenePath Dx
  11.8.1 GenePath Dx Company Details
  11.8.2 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Offered
  11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.8.4 GenePath Dx Main Business Overview
  11.8.5 GenePath Dx News
11.9 Illumina, Inc.
  11.9.1 Illumina, Inc. Company Details
  11.9.2 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
  11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.9.4 Illumina, Inc. Main Business Overview
  11.9.5 Illumina, Inc. News
11.10 Laboratory Corporation of America Holdings
  11.10.1 Laboratory Corporation of America Holdings Company Details
  11.10.2 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Offered
  11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
  11.10.4 Laboratory Corporation of America Holdings Main Business Overview
  11.10.5 Laboratory Corporation of America Holdings News
11.11 Myriad Genetics, Inc.
11.12 QIAGEN N.V.
11.13 Quest Diagnostics Incorporated
11.14 Siemens Healthineers, Inc.
11.15 Thermo Fisher Scientific Inc.
11.16 HTG Molecular Diagnostics, Inc.
11.17 Vela Diagnostics Pte. Ltd.

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. NGS-Based Monitoring and Diagnostic Test Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Commercial Assays/Tests
Table 3. Major Players of Laboratory Developed Tests
Table 4. Major Players of Direct to Consumer Test
Table 5. Major Players of Pre-Commercial Tests
Table 6. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029) ($ Millions)
Table 7. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Table 8. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029) ($ Millions)
Table 9. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Table 10. Date of Global Key Players Enter into NGS-Based Monitoring and Diagnostic Test Market
Table 11. Global Key Players NGS-Based Monitoring and Diagnostic Test Product Offered
Table 12. Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players NGS-Based Monitoring and Diagnostic Test Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. NGS-Based Monitoring and Diagnostic Test New Product/Technology Launches
Table 18. NGS-Based Monitoring and Diagnostic Test Industry Partnerships, Agreements, and Collaborations
Table 19. NGS-Based Monitoring and Diagnostic Test Industry Mergers and Acquisitions
Table 20. Global NGS-Based Monitoring and Diagnostic Test Market Size by Regions 2024-2029 ($ Millions)
Table 21. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions 2024-2029
Table 22. United States NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029) ($ Millions)
Table 23. United States NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Table 24. United States NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029) ($ Millions)
Table 25. United States NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Table 26. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029) ($ Millions)
Table 27. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Table 28. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029) ($ Millions)
Table 29. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Table 30. China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029) ($ Millions)
Table 31. China NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Table 32. China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029) ($ Millions)
Table 33. China NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Table 34. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2029) ($ Millions)
Table 35. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Table 36. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2029) ($ Millions)
Table 37. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Table 38. Key Market Drivers & Growth Opportunities of NGS-Based Monitoring and Diagnostic Test
Table 39. Key Market Challenges & Risks of NGS-Based Monitoring and Diagnostic Test
Table 40. Key Industry Trends of NGS-Based Monitoring and Diagnostic Test
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. Agilent Technologies, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 55. Ancestry.com LLC Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 57. ArcherDX, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 59. Beijing Genomics Institute (BGI) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 61. Cancer Genetics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 63. CENTOGENE AG Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 65. F. Hoffmann-La Roche Ltd Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 67. GenePath Dx Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. GenePath Dx NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 69. Illumina, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 71. Laboratory Corporation of America Holdings Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 73. Myriad Genetics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 74. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 75. QIAGEN N.V. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 76. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 77. Quest Diagnostics Incorporated Basic Information, Head Office, Major Market Areas and Its Competitors
Table 78. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 79. Siemens Healthineers, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 80. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 81. Thermo Fisher Scientific Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 82. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 83. HTG Molecular Diagnostics, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 84. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)
Table 85. Vela Diagnostics Pte. Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table 86. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of NGS-Based Monitoring and Diagnostic Test
Figure 2. NGS-Based Monitoring and Diagnostic Test Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. NGS-Based Monitoring and Diagnostic Test Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2024-2029)
Figure 9. Global Commercial Assays/Tests Market Size Growth Rate
Figure 10. Global Laboratory Developed Tests Market Size Growth Rate
Figure 11. Global Direct to Consumer Test Market Size Growth Rate
Figure 12. Global Pre-Commercial Tests Market Size Growth Rate
Figure 13. NGS-Based Monitoring and Diagnostic Test in Out-Patient Clinics/General Practitioners
Figure 14. Global NGS-Based Monitoring and Diagnostic Test Market: Out-Patient Clinics/General Practitioners (2024-2029) ($ Millions)
Figure 15. NGS-Based Monitoring and Diagnostic Test in Diagnostic Centers
Figure 16. Global NGS-Based Monitoring and Diagnostic Test Market: Diagnostic Centers (2024-2029) ($ Millions)
Figure 17. NGS-Based Monitoring and Diagnostic Test in Hospitals
Figure 18. Global NGS-Based Monitoring and Diagnostic Test Market: Hospitals (2024-2029) ($ Millions)
Figure 19. NGS-Based Monitoring and Diagnostic Test in Others
Figure 20. Global NGS-Based Monitoring and Diagnostic Test Market: Others (2024-2029) ($ Millions)
Figure 21. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2024-2029)
Figure 22. Global NGS-Based Monitoring and Diagnostic Test Market Size in Out-Patient Clinics/General Practitioners Growth Rate
Figure 23. Global NGS-Based Monitoring and Diagnostic Test Market Size in Diagnostic Centers Growth Rate
Figure 24. Global NGS-Based Monitoring and Diagnostic Test Market Size in Hospitals Growth Rate
Figure 25. Global NGS-Based Monitoring and Diagnostic Test Market Size in Others Growth Rate
Figure 26. Funding/Investment
Figure 27. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Regions 2024-2029
Figure 28. United States NGS-Based Monitoring and Diagnostic Test Market Size 2024-2029 ($ Millions)
Figure 29. China NGS-Based Monitoring and Diagnostic Test Market Size 2024-2029 ($ Millions)
Figure 30. Europe NGS-Based Monitoring and Diagnostic Test Market Size 2024-2029 ($ Millions)
Figure 31. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size 2024-2029 ($ Millions)
Figure 32. United States NGS-Based Monitoring and Diagnostic Test Consumption Market Share by Type in 2029
Figure 33. United States NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2029
Figure 34. China NGS-Based Monitoring and Diagnostic Test Consumption Market Share by Type in 2029
Figure 35. China NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2029
Figure 36. Europe NGS-Based Monitoring and Diagnostic Test Consumption Market Share by Type in 2029
Figure 37. Europe NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2029
Figure 38. Rest of World NGS-Based Monitoring and Diagnostic Test Consumption Market Share by Type in 2029
Figure 39. Rest of World NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application in 2029